The DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
Coordinate regulation of ribosome biogenesis and function by the ribosomal protein S6 kinase, a key mediator of mTOR function
Abstract
Current understanding of the mechanisms by which cell growth is regulated lags significantly behind our knowledge of the complex processes controlling cell cycle progression. Recent studies suggest that the mammalian target of rapamycin (mTOR) pathway is a key regulator of cell growth via the regulation of protein synthesis. The key mTOR effectors of cell growth are eukaryotic initiation factor 4E-binding protein 1 (4EBP-1) and the ribosomal protein S6 kinase (S6K). Here we will review the current models for mTOR dependent regulation of ribosome function and biogenesis as well as its role in coordinating growth factor and nutrient signaling to facilitate homeostasis of cell growth and proliferation. We will place particular emphasis on the role of S6K1 signaling and will highlight the points of cross talk with other key growth control pathways. Finally, we will discuss the impact of S6K signaling and the consequent feedback regulation of the PI3K/Akt pathway on disease processes including cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activation of p70S6K is mediated by sequential phosphorylation on multiple sites by mTOR and PDK1, which is counteracted by PP2A/B56γ (Hahn et al., 2010; Jastrzebski et al., 2007).”
From PP2A holoenzymes, substrate specificity driving cellular functions and deregulation in cancer (2019) · cites this paper as Jastrzebski et al., 2007
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Kim, D., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument‐Bromage, H., Tempst, P., & Sabatini, D. M. (2002) · Cell · doi:10.1016/s0092-8674(02)00808-5 · Cited by 3,051
The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1
Hanks, S. K., & Hunter, T. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.8.7768349 · Cited by 2,828
Sarbassov, D. D., Ali, S. M., Kim, D.-H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.054 · Cited by 2,665
Hanks, S. K., & Hunter, T. R. (1995) · PubMed · Cited by 2,518
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
Sarbassov, D. D., Ali, S. M., Sengupta, S., Sheen, J.-H., Hsu, P. P., Bagley, A. F., Markhard, A. L., & Sabatini, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.029 · Cited by 2,365
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Rüegg, M. A., Hall, A., & Hall, M. N. (2004) · Nature Cell Biology · doi:10.1038/ncb1183 · Cited by 2,097
Cited by
Sorted by citations
Items 101–200 of 241
mTOR function in skeletal muscle: a focal point for overnutrition and exercise
Rivas, D. A., Lessard, S. J., & Coffey, V. G. (2009) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h09-073 · Cited by 39
Kawata, K., Hatano, A., Yugi, K., Kubota, H., Sano, T., Fujii, M., Tomizawa, Y., Kokaji, T., Tanaka, K. Y., Uda, S., et al. (2018) · iScience · doi:10.1016/j.isci.2018.07.022 · Cited by 36
Signaling to the ribosome in cancer—It is more than just mTORC1
Hannan, K. M., Sanij, E., Hein, N., Hannan, R. D., & Pearson, R. B. (2011) · IUBMB Life · doi:10.1002/iub.428 · Cited by 44
Protein translation paradox: Implications in translational regulation of aging
Kim, H. S., & Pickering, A. M. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1129281 · Cited by 43
Martineau, Y., Wang, X., Alain, T., Petroulakis, E., Shahbazian, D., Fabre, B., Bousquet, M., Monsarrat, B., Pyronnet, S., & Sonenberg, N. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01079-13 · Cited by 38
Ismail, H. M. (2012) · Journal of Oncology · doi:10.1155/2012/416927 · Cited by 39
Boultwood, J., Yip, B. H., Vuppusetty, C., Pellagatti, A., & Wainscoat, J. S. (2012) · Advances in Biological Regulation · doi:10.1016/j.jbior.2012.09.002 · Cited by 36
Pujhari, S. K., Kryworuchko, M., & Zakhartchouk, A. N. (2014) · Virus Research · doi:10.1016/j.virusres.2014.09.017 · Cited by 36
Chen, Y., Navarrete, M. S., Wang, Y., McClintock, N. C., Sakurai, R., Wang, F., Chen, K. T., Chou, T., Rehan, V. K., Lee, D. J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-68615-w · Cited by 36
Genetics and Pharmacology of Longevity
Castillo-Quan, J. I., Kinghorn, K. J., & Bjedov, I. (2015) · Advances in genetics · doi:10.1016/bs.adgen.2015.06.002 · Cited by 37
Mao, J., Luo, H., Han, B., Bertrand, R., & Wu, J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802255 · Cited by 32
Alattar, A., Alshaman, R., Althobaiti, Y. S., Soliman, G. M., Ali, H. S., Khubrni, W. S., Koh, P., Rehman, N. U., & Shah, F. A. (2023) · Pharmaceuticals · doi:10.3390/ph16081182 · Cited by 32
Huang, H.-G., Luo, X., Wu, S., & Jian, B. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.12.4937 · Cited by 31
Lou, F., Gao, T., & Han, Z. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.08.223 · Cited by 31
Cellular Effects of Everolimus and Sirolimus on Podocytes
Müller-Krebs, S., Weber, L., Tsobaneli, J., Kihm, L., Reiser, J., Zeier, M. G., & Schwenger, V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080340 · Cited by 31
Afzal, O., Altamimi, A. S. A., Mubeen, B., Alzarea, S. I., Almalki, W. H., Al-Qahtani, S. D., Atiya, E. M., Al-Abbasi, F. A., Ali, F., Ullah, I., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012470 · Cited by 36
Ndong, M., Kazami, M., Suzuki, T., Uehara, M., Katsumata, S.-I., Inoue, H., Kobayashi, K., Tadokoro, T., Suzuki, K., & Yamamoto, Y. (2009) · Nutrition Research · doi:10.1016/j.nutres.2009.09.007 · Cited by 30
Thomé, C. H., dos Santos, G. A., Ferreira, G. A., Scheucher, P. S., Izumi, C., Leopoldino, A. M., Simão, A. M., Ciancaglini, P., de Oliveira, K. T., Chin, A. P., et al. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.019661 · Cited by 33
Oyama, K., Takahashi, K., & Sakurai, K. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.501 · Cited by 30
Yang, D., Qu, J., Qu, X., Cao, Y., Xu, L., Hou, K., Feng, W., & Liu, Y. (2015) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-015-2749-0 · Cited by 29
Activation of the mTORC1 and STAT3 pathways promotes the malignant transformation of colitis in mice
He, Z., He, X., Chen, Z., Ke, J., He, X., Yuan, R., Cai, Z., CHEN, X., Wu, X., & Lan, P. (2014) · Oncology Reports · doi:10.3892/or.2014.3421 · Cited by 29
A Weak C′ Box Renders U3 snoRNA Levels Dependent on hU3-55K Binding
Knox, A. A., McKeegan, K. S., Debieux, C. M., Traynor, A., Richardson, H., & Watkins, N. J. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05067-11 · Cited by 32
Lymphangioleiomyomatosis and TSC2 -/- Cells
Darling, T. N., Pacheco–Rodriguez, G., Gorio, A., Lesma, E. A., Walker, C. L., & Moss, J. (2010) · Lymphatic Research and Biology · doi:10.1089/lrb.2009.0031 · Cited by 28
Rajamäki, M., Xi, D., Sikorskaitė-Gudžiūnienė, S., Valkonen, J. P. T., & Whitham, S. A. (2017) · Molecular Plant-Microbe Interactions · doi:10.1094/mpmi-06-16-0122-r · Cited by 28
Singh, S., Saraiva, L., Elkington, P. T., & Friedland, J. S. (2013) · The FASEB Journal · doi:10.1096/fj.13-235507 · Cited by 27
Satheesha, S., Cookson, V. J., Coleman, L., Ingram, N., Madhok, B., Hanby, A. M., Suleman, C. A. B., Sabine, V. S., Macaskill, E. J., Bartlett, J. M. S., et al. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-19 · Cited by 27
Epigenetic Engineering of Ribosomal RNA Genes Enhances Protein Production
Santoro, R., Lienemann, P. S., & Fussenegger, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006653 · Cited by 28
Ismail, H. M., Myronova, O., Tsuchiya, Y., Niewiarowski, A., Tsaneva, I. R., & Gout, I. T. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.02.002 · Cited by 25
Zhang, Z., Liu, R., Townsend, P. A., & Proud, C. G. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.03.006 · Cited by 25
van Erp, N. P., van Herpen, C. M., de Wit, D., Willemsen, A. E. C. A. B., Burger, D. M., Huitema, A. D. R., Kapiteijn, E., & ter Heine, R. (2016) · Clinical Pharmacokinetics · doi:10.1007/s40262-016-0414-3 · Cited by 24
Nardella, C., Lunardi, A., Fedele, G., Clohessy, J. G., Alimonti, A., Kozma, S. C., Thomas, G., Loda, M. F., & Pandolfi, P. P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3962 · Cited by 23
Zhu, J., Han, L., Liu, R., Zhang, Z., Huang, Q., Fang, X., Yang, K., Huang, G., Zheng, Z., Yawalkar, N., et al. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-03006-x · Cited by 22
Evaluation of mTOR-Regulated mRNA Translation
Iadevaia, V., Wang, X., Yao, Z., Foster, L. J., & Proud, C. G. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-430-8_10 · Cited by 22
Major Physiological Signaling Pathways in the Regulation of Cell Proliferation and Survival
Tang, H., & Xue, G. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_4 · Cited by 22
Jungers, C. F., Elliff, J. M., Masson‐Meyers, D. S., Phiel, C. J., & Origanti, S. S. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013324 · Cited by 21
Peng, Y., Liou, B., Lin, Y., Fannin, V., Zhang, W., Feldman, R. A., Setchell, K. D. R., Grabowski, G. A., & Sun, Y. (2021) · Cells · doi:10.3390/cells10092286 · Cited by 21
mTORC1 regulates the efficiency and cellular capacity for protein synthesis
Proud, C. G. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130036 · Cited by 24
Akhenblit, P. J., Hanke, N. T., Gill, A., Persky, D. O., Howison, C. M., Pagel, M. D., & Baker, A. F. (2016) · Molecular Imaging · doi:10.1177/1536012116645439 · Cited by 21
Nucleolar disruption leads to the spatial separation of key 18S rRNA processing factors
Turner, A. J., Knox, A. A., & Watkins, N. J. (2012) · RNA Biology · doi:10.4161/rna.18811 · Cited by 21
Breast Carcinoma Cells in Primary Tumors and Effusions Have Different Gene Array Profiles
Konstantinovsky, S., Smith, Y., Zilber, S., Stavnes, H. T., Becker, A.-M., Nesland, J. M., Reich, R., & Davidson, B. (2009) · Journal of Oncology · doi:10.1155/2010/969084 · Cited by 22
Gwalter, J., Wang, M.-L., & Gout, I. T. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.08.018 · Cited by 21
Alack, K., Weiß, A., Krüger, K., Höret, M., SCHERMULY, R. T., Frech, T., Eggert, M., & Mooren, F. (2020) · Scientific Reports · doi:10.1038/s41598-020-57676-6 · Cited by 21
Jastrzebski, K., Hannan, K. M., House, C. M., Hung, S. S. C., Pearson, R. B., & Hannan, R. D. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.03.016 · Cited by 19
Li, Q., Han, Y., Du, J., Jin, H., Zhang, J., Niu, M., & Qin, J. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2443-1 · Cited by 19
Xu, P., Chen, Q., Chen, X., Qi, H., Yang, Y., Li, W., Yang, X., Gunawan, A., Chen, S., Zhang, H., et al. (2022) · GeroScience · doi:10.1007/s11357-022-00693-2 · Cited by 17
The Ribosomal Gene Loci—The Power behind the Throne
Panov, K. I., Hannan, K. M., Hannan, R. D., & Hein, N. (2021) · Genes · doi:10.3390/genes12050763 · Cited by 19
Kay, N. E., Sassoon, T., Secreto, C. R., Sinha, S., Shanafelt, T. D., Ghosh, A. K., & Arbiser, J. L. (2016) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2016.1161186 · Cited by 16
The mTOR downstream regulator (p-4EBP1) is a novel independent prognostic marker in ovarian cancer
Alabdullah, M. L., Ahmad, D. A. J., Moseley, P. M., Madhusudan, S., Chan, S. Y. T., & Rakha, E. A. (2019) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2018.1534091 · Cited by 16
Prazosin induces p53-mediated autophagic cell death in H9C2 cells
Yang, Y., Wu, C., Chen, W., Chen, Y., & Su, M. (2011) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-011-0657-3 · Cited by 16
Prediction of genetic risk factors of atherosclerosis using various bioinformatic tools
Wang, H., & Zhao, Y. X. (2016) · Genetics and Molecular Research · doi:10.4238/gmr.15027347 · Cited by 15
Sekihara, K., Saitoh, K., Yang, H., Kawashima, H., Kazuno, S., Kikkawa, M., Arai, H., Miida, T., Hayashi, N., Sasai, K., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199117 · Cited by 15
Khan, H., Singh, A. P., Singh, Y., Sharma, D., Dua, K., Grewal, A. K., & Singh, T. G. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01543-8 · Cited by 14
Gao, X., Li, P., Mei, J., & Xie, J. (2021) · Journal of Chemistry · doi:10.1155/2021/8876986 · Cited by 14
Kalaeva, E., Kalaev, V., Efimova, K., Chernitskiy, A., & Safonov, V. (2019) · Veterinary World · doi:10.14202/vetworld.2019.1657-1667 · Cited by 13
Broering, R., Trippler, M., Werner, M., Real, C. I., Megger, D. A., Bracht, T., Schweinsberg, V., Sitek, B., Eisenacher, M., Meyer, H. E., et al. (2016) · Journal of Viral Hepatitis · doi:10.1111/jvh.12508 · Cited by 13
The role of the mTOR pathway in regulating food intake.
Wiczer, B. M., & Thomas, G. (2010) · PubMed · Cited by 13
Transcriptome Analysis of Marbled Rockfish Sebastiscus marmoratus under Salinity Stress
He, Z., Shou, C., & Han, Z. (2023) · Animals · doi:10.3390/ani13030400 · Cited by 12
Stock, A. T., Parsons, S. A., D’Silva, D. B., Hansen, J. A., Sharma, V. J., James, F., Starkey, G., D’Costa, R., Gordon, C. L., & Wicks, I. P. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42340 · Cited by 12
Wang, W., Choi, R. H., Solares, G. J., Tseng, H.-M., Ding, Z., Kim, K., & Ivy, J. L. (2015) · Amino Acids · doi:10.1007/s00726-015-1972-7 · Cited by 12
Molina, L. D. P., Torres, J. M., Rodríguez‐Pena, R., & López‐Granados, E. (2020) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.21956 · Cited by 12
Song, S., Abdelmohsen, K., Zhang, Y., Becker, K. G., Gorospe, M., & Bernier, M. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.185678 · Cited by 11
Smirlis, D., Dingli, F., Pescher, P., Prina, E., Loew, D., Rachidi, N., & Späth, G. F. (2019) · Journal of Proteomics · doi:10.1016/j.jprot.2019.103617 · Cited by 11
Involvement of mTOR in Type 2 CRF Receptor Inhibition of Insulin Signaling in Muscle Cells
Chao, H., Li, H., Grande, R. C., Lira, V. A., Yan, Z., Harris, T. E., & Li, C. (2015) · Molecular Endocrinology · doi:10.1210/me.2014-1245 · Cited by 10
Temiz, T. K., Altun, A., Turgut, N. H., & Balcı, E. (2014) · Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi · doi:10.7197/1305-0028.33144 · Cited by 10
IKBKE inhibits TSC1 to activate the mTOR/S6K pathway for oncogenic transformation
Göktuna, S. İ. (2018) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-1801-57 · Cited by 10
The coordinated management of ribosome and translation during injury and regeneration
Nguyen, T., Mills, J. C., & Cho, C. J. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1186638 · Cited by 9
Peña-Uribe, C. A., García‐Pineda, E., Beltrán-Peña, E. M., & de la Cruz, H. R. (2012) · Plant Growth Regulation · doi:10.1007/s10725-012-9672-8 · Cited by 9
Kim, J. H., Jung, K., Lee, C., Song, D., Kim, K., Yoo, H. C., Park, S. J., Kang, J. S., Lee, K., Kim, S., et al. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.104907 · Cited by 9
Abrisqueta, M., Süren‐Castillo, S., & Maestro, J. L. (2016) · Physiological Entomology · doi:10.1111/phen.12156 · Cited by 9
Kinase Inhibitors with Antiepileptic Properties Identified with a Novel in Vitro Screening Platform
Liu, J., Schenker, M., Ghiasvand, S., & Berdichevsky, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102502 · Cited by 8
Schreiber, K. H., O’Leary, M. N., & Kennedy, B. K. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-411596-5.00002-2 · Cited by 7
Gene expression profiles in whole blood and associations with metabolic dysregulation in obesity
Cox, A. J., Zhang, P., Evans, T. J., Scott, R. J., Cripps, A. W., & West, N. P. (2017) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2017.07.001 · Cited by 7
CRISPR screening identifies T cell-intrinsic regulators of CD3-bispecific antibody responses
Molony, R. D., Funk, T., Trabucco, G. M., Corcoran, E., Ruddy, D. A., Varadarajan, M., Elliot, G., Piquet, M., Lam, J. W., Meyer, M. J., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.909979 · Cited by 6
Kitagishi, Y. (2014) · International Neuropsychiatric Disease Journal · doi:10.9734/indj/2014/5691 · Cited by 6
Global identification of genes and pathways regulated by Akt during activation of T helper cells
Cheng, J., & Kane, L. (2013) · F1000Research · doi:10.12688/f1000research.2-109.v1 · Cited by 6
Downregulation of mTOR by lentivirus inhibits prostate cancer cell growth.
Du, Y., Long, Q., Shi, Y. Q., Liu, X.-G., Li, X., Zeng, J., Gong, Y., Wang, X., & He, D. (2014) · Europe PMC (PubMed Central) · Cited by 5
A Review of Compounds for Prevention of Colorectal Cancer
Namani, A., Li, J., Wang, X. J., & Tang, X. (2017) · Current Pharmacology Reports · doi:10.1007/s40495-017-0101-6 · Cited by 5
Kim, D. S., Murvelashvili, N., Hamidi, O., & Jia, L. (2022) · International Journal of Surgical Pathology · doi:10.1177/10668969221117246 · Cited by 4
Sun, S., He, Z., Zhang, F., & Han, Z. (2024) · Frontiers in Marine Science · doi:10.3389/fmars.2024.1491685 · Cited by 4
Ray, P. D., Maclellan, R. A., He, J., Liu, Z., & Wu, J. (2014) · ISRN Obesity · doi:10.1155/2014/540582 · Cited by 4
Zhao, R., Li, Y., Liu, Y., Yang, X., Li, H., Wu, C., Zhao, Z., Yan, Y., Liu, Z., Li, S., et al. (2025) · Phytotherapy Research · doi:10.1002/ptr.70004 · Cited by 3
Monitoring endoplasmic reticulum stress responsive mRNAs by RNA sequencing
Okuda, T., Wakaguri, H., Suzuki, Y., & Sugano, S. (2012) · Gene · doi:10.1016/j.gene.2012.03.048 · Cited by 3
The Role of Ribosome Biogenesis in Skeletal Muscle Hypertrophy
Figueiredo, V. C., & McCarthy, J. J. (2017) · Springer eBooks · doi:10.1007/978-981-10-3292-9_6 · Cited by 3
Diverse Mechanisms of Translation Regulation and Their Role in Cancer
Villa, N., & Fraser, C. S. (2014) · Springer eBooks · doi:10.1007/978-94-017-9078-9_3 · Cited by 3
Fonseca, B. D., & Proud, C. G. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-271-1_9 · Cited by 5
Impact of Rapamycin on Longevity: Updated Insights
Sanati, M., Afshari, A. R., Aminyavari, S., Banach, M., & Sahebkar, A. (2024) · Archives of Medical Science · doi:10.5114/aoms/191565 · Cited by 3
Unraveling the impact of ZZZ3 on the mTOR/ribosome pathway in human embryonic stem cells homeostasis
Conte, M. L., Lucchino, V., Scalise, S., Zannino, C., Valente, D., Rossignoli, G., Murfuni, M. S., Cicconetti, C., Scaramuzzino, L., Matassa, D. S., et al. (2024) · Stem Cell Reports · doi:10.1016/j.stemcr.2024.04.002 · Cited by 2
Inhibition of protein translation under matrix-deprivation stress in breast cancer cells
Warrier, S., Srinivasan, S., Chedere, A., & Rangarajan, A. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1124514 · Cited by 2
Molecular Genetic Markers in Female Reproductive Cancers
Wang, T., Davidson, B., Buckhaults, P., Huang, C., & Pohl, G. (2010) · Journal of Oncology · doi:10.1155/2010/307460 · Cited by 2
The Regulation of Mammalian Target of Rapamycin
Xie, J. (2012) · Figshare · Cited by 2
Liu, T., Li, Z., Zhang, W., Guo, X., Liu, G., Yang, D., & Yang, S. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1564458 · Cited by 1
Lashen, S. A. A. (2017) · Journal of Liver Research Disorders & Therapy · doi:10.15406/jlrdt.2017.03.00056
Downstream of mTOR: Translational Control of Cancer
Dowling, R. J. O., & Sonenberg, N. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-271-1_10 · Cited by 1
Cho, D. C. (2010) · Clinical Medicine Reviews in Oncology · doi:10.4137/cmro.s3428 · Cited by 1
Pavan, I. C. B., Silva, F. R., Morelli, A. P., & Simabuco, F. M. (2016) · Springer eBooks · doi:10.1007/978-1-4614-6438-9_101816-1 · Cited by 1
Regulation of autophagy and mTOR during Semliki Forest virus infection
Eng, K. E. (2012) · Figshare
The Role of TIPE2 in the Regulation of Inflammation and Tumorigenesis
Johnson, D. (2013) · Scholarly Commons (University of Pennsylvania)
Targeting the mTOR Pathway for Tumor Therapeutics
Chen, W. (2009) · Wiley eBooks · doi:10.1002/9780470538951.ch22
Rutas de señalización de la insulina en plantas
Peña, E. M. B., Domínguez, A. J., Fierros‐Romero, G., Mellado-Rojas, M. E., de la Cruz, H. R., & Pineda, E. G. (2011) · Ciencia Nicolaita · doi:10.35830/cn.vi54.31
Clinical potential of the mTOR effectors S6K1, S6K2 and 4EBP1 in breast cancer
Karlsson, E. A. (2014) · Linköping University Electronic Press eBooks · doi:10.3384/diss.diva-104180
Metadata
- Authors
- Jastrzebski, K., Hannan, K. M., Tchoubrieva, E. B., Hannan, R. D., & Pearson, R. B.
- Affiliations
- The University of Melbourne (AU)
- Peter MacCallum Cancer Centre (AU)
- Corresponding author
- Pearson, Richard B.
- Venue
- Growth Factors
- Publisher
- Informa UK Limited
- Published
- 2007-01
- Volume
- 25
- Issue
- 4
- Pages
- 209-226
- ISSN
- 0897-7194 (ISSN-L)
- 1029-2292
- OpenAlex
- W2093579930
- Cited by
- 240
- References
- 194
- Citations by year
- 2025: 4 · 2024: 4 · 2023: 7 · 2022: 6 · 2021: 18 · 2020: 7 · 2019: 10 · 2018: 8 · 2017: 12 · 2016: 10 · 2015: 16 · 2014: 25 · 2013: 25 · 2012: 20
- FWCI
- 5.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Growth Factors (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Health and Medical Research Council
- National Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- ribosome biogenesis, ribosome function, S6K, S6K1, mTOR signaling, 4E-BP1, cell growth regulation, protein synthesis, nutrient signaling, growth factor signaling, PI3K/Akt signaling, signaling crosstalk, cancer
- MeSH terms
- Protein Kinases, Ribosomes, RNA, Ribosomal, Protein Biosynthesis, Signal Transduction, Phosphatidylinositol 3-Kinases, Ribosomal Protein S6 Kinases, Cell Growth Processes, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review